+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Monoclonal Antibodies Market - Global Forecast 2026-2032 - Product Thumbnail Image

Monoclonal Antibodies Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 185 Pages
  • Global
From
Psoriasis Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Psoriasis Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 191 Pages
  • Global
From
Neutropenia Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Neutropenia Treatment Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 198 Pages
  • Global
From
Hyaluronic Acid Raw Material Market - Global Forecast 2026-2032 - Product Thumbnail Image

Hyaluronic Acid Raw Material Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 195 Pages
  • Global
From
From
Immunomodulators Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immunomodulators Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 184 Pages
  • Global
From
From
From
Bullous pemphigoid Market - Global Forecast 2026-2032 - Product Thumbnail Image

Bullous pemphigoid Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 186 Pages
  • Global
From
Skin Allergy Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Skin Allergy Therapeutics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 186 Pages
  • Global
From
Vitiligo Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Vitiligo Therapeutics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 199 Pages
  • Global
From
Chondroitin for Pets Market - Global Forecast to 2030 - Product Thumbnail Image

Chondroitin for Pets Market - Global Forecast to 2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
Dog Chondroitin Market - Global Forecast 2025-2030 - Product Thumbnail Image

Dog Chondroitin Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
IL-1 Receptor Antagonist Market - Global Forecast 2025-2030 - Product Thumbnail Image

IL-1 Receptor Antagonist Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 183 Pages
  • Global
From
IL-12 Receptor Antagonist Market - Global Forecast 2025-2030 - Product Thumbnail Image

IL-12 Receptor Antagonist Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 180 Pages
  • Global
From
IL-6 Receptor Antagonist Market - Global Forecast 2025-2030 - Product Thumbnail Image

IL-6 Receptor Antagonist Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
IL-23 Receptor Antagonist Market - Global Forecast 2025-2030 - Product Thumbnail Image

IL-23 Receptor Antagonist Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 192 Pages
  • Global
From
Selective Immunosuppressants Market - Global Forecast 2025-2030 - Product Thumbnail Image

Selective Immunosuppressants Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 193 Pages
  • Global
From
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more